Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo …

By
riskacademy
-
0
247
  1. Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo …  The Lancet

    2. Full coverage

Подробнее…

Актуальные книги на английском

RELATED ARTICLESMORE FROM AUTHOR